SI
UTHR icon

Seeds Investor’s United Therapeutics UTHR Stock Holding History

Seeds Investor’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Sell
1,011
-59
-6% -$33.2K 0.06% 211
2026
Q1 		$619K Sell
1,070
-406
-28% -$202K 0.08% 167
2025
Q4 		$719K Buy
1,476
+130
+10% +$60.5K 0.14% 104
2025
Q3 		$564K Buy
1,346
+38
+3% +$12.8K 0.12% 104
2025
Q2 		$376K Sell
1,308
-140
-10% -$41.8K 0.09% 143
2025
Q1 		$446K Sell
1,448
-234
-14% -$80.2K 0.13% 116
2024
Q4 		$593K Buy
1,682
+102
+6% +$37.5K 0.17% 89
2024
Q3 		$566K Buy
1,580
+260
+20% +$87.8K 0.21% 88
2024
Q2 		$420K Buy
+1,320
New +$349K 0.22% 100

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Seeds Investor's UTHR Position: Q2 2026 in Review

Seeds Investor reduced its United Therapeutics (UTHR) stake by 5.5% in Q2 2026, selling an estimated $33.2K and leaving 1,011 shares worth $548K. The position accounts for 0.06% of the portfolio, ranked #211.

Seeds Investor first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $719K in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Seeds Investor held 1,011 shares of United Therapeutics worth $548K as of Q2 2026.
  • Seeds Investor sold 59 United Therapeutics shares in Q2 2026, an estimated $33.2K.
  • United Therapeutics made up 0.06% of Seeds Investor's portfolio in Q2 2026, its #211 holding.
  • Seeds Investor first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Seeds Investor's United Therapeutics position peaked at $719K in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Seeds Investor's 13F filing for Q2 2026, filed 12 Aug 2026.